Recent Updates
Recently added Catalysts
LNTH Positive Sentiment

Lantheus to Host Fourth Quarter and Full Year 2025 Earnings Conference Call and Webcast on February 26, 2026, at 8:00 a.m. Eastern Time

Key Takeaway: Lantheus Holdings, Inc. announced a conference call scheduled for February 26, 2026, at 8:00 a.m. ET to discuss its financial results for Q4 and the full year of 2025. Participants are encouraged to register online in advance to avoid delays. A replay will be available shortly after the call.
Price reaction · baseline $67.28 (2026-02-11 close) · hit pre-market · clean, no other LNTH news in the window
day 0 close · peak
+2.1%

Market Sentiment Analysis

POSITIVE FACTORS

  • Lantheus is hosting a conference call to discuss strong financial results.
  • The company has a long history of providing radiopharmaceutical solutions.
  • Participants can easily access the webcast and replay.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+48%
120-day peak, hindsight
Typical move
2%
average across 7 past catalysts
Lead asset
18F-DCFPyL
Phase 3 · Prostate Cancer

Full Press Release Details

BEDFORD, Mass., Feb. 12, 2026 (GLOBE NEWSWIRE) --Lantheus Holdings, Inc.(the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Thursday, February 26, 2026, to discuss its financial and operating results for the fourth quarter and full year of 2025.
To access the conference call or webcast, participants should register online athttps://investor.lantheus.com/news-events/calendar-of-events. To avoid delays, we encourage participants to register fifteen minutes ahead of the scheduled start time.
A replay will be available approximately two hours after completion of the webcast and will be archived on the same web page for at least 30 days.

About Lantheus

Lantheus is the leading radiopharmaceutical-focused company, delivering life-changing science to enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes. Headquartered in Massachusetts with offices in New Jersey, Canada, Germany, Sweden, Switzerland, and the United Kingdom, Lantheus has been providing radiopharmaceutical solutions for 70 years. For more information, visitwww.lantheus.com.

Frequently Asked Questions

When is Lantheus's earnings conference call?

The earnings conference call is scheduled for February 26, 2026, at 8:00 a.m. ET.

How can I access the Lantheus webcast?

Participants can register online at Lantheus's investor website to access the webcast.

Will there be a replay of the earnings call?

Yes, a replay will be available approximately two hours after the call.

What will be discussed during the earnings call?

The call will discuss Lantheus's financial and operating results for Q4 and the full year of 2025.

Last updated: Feb 12, 2026